in Paris at Jacques Glowinski's laboratory 1973–1977. Oxford University, MRC Unit of Clinical Pharmacology and Faculty of Medicine 1977–1995. Technion-Israel Institute of Technology Medical School, Professor and Chairman 1983-2010. Finkelstein Professor of Life sciences, Technion-Israel Institute of Technology 1991–1999. International Scholar in Residence at NIH Fogarty International Center for Advanced Study in Human Health Sciences, Bethesda 1997–2012. Directors of Eve Top Center of Excellence for Neurodegenerative Diseases Research and Teaching and USA National Parkinson Disease Center of Excellence, Technion Faculty of Medicine 2006-2008 Distinguished Scientific Professor at Hong Kong Polytechnic University and Department of Anatomy Hong Kong University 2008–2013. Distinguished Professor of Neurobiology at Yonsei World Class University Programme, Seoul, South Korea. He holds professorships at Armed Forces University Medical School in Bethesda; and in China Janin University, Materia Medica Shanghai University of Chinese Traditional Medicine; Ruijin Medical school, Shanghai and Qingdao University. Industry involvement Youdim served as consultant to Roche, TEVA Pharmaceuticals Ltd; Ciba Geigy, and Continental Pharmaceuticals,Brussels. He is president and CSO of Youdim Pharmaceutical. He is a discoverer of the anti-Parkinson drugs selelgiline (l-deprenyl) and developer of monoamine oxidase B inhibitor rasagiline (Azilect), which was considered to be the first disease modifying drug used for Parkinson's disease and TVP 3326, ladostigil, for Alzheimer's disease. Experts have recently questioned whether rasagiline actually has significant disease modifying properties. Recognition 1974. Anna Monika International Prize, Basel, Switzerland. 1974. British Migraine Association Special Gold Medal, London, UK. 1978. The Homayoon (Royal) Medal from the Shah, Tehran, Iran. 1980. National Israel Psychobiology Institute Prize, Jerusalem, Israel. 1986. Michael Landau Research Prize, Tel Aviv, Israel. 1984. United States Department of Commerce, Inventor's Award, Isolation and cuLture of Adrenal Meduallry Endothelial Cells Producing Blood Clotting Factor 8. 1990. Senator Burda International Prize for Parkinson's disease, Vienna, Austria. 1991. Claudius Galenus Gold Medal Prize Drug of the year l-Deprenyl (selegiline), Berlin, Germany. 1991. Deutscher Neuropharmakologie (AGNP) Prize, Nuremberg, Germany. 1991. Eli Lilly Prize for Neuropharmacology, Indianapolis, USA. 1993. The New England Prize of Excellence in Science, Boston, USA. 1994 and 1977. Henning Andersen Prize, Stockholm, Sweden. 1997. "Honoris Causa" Honorary Doctor of Philosophy, Semmelweiss University Medical School, Hungary. 1998. "Honoris Causa" Honorary Doctor Of the Philosophy University of Pisa and Ecole Superior Nationale, Pisa, Italy. 2006. Henry Taub Prize for Excellence in Research, Technion-Israel Institute of Technology, Haifa, Israel. 2006. Nathan Shock Lecture, NIH Institute of Aging, Bethesda, USA. 2007. Melvin Yahr Lecture, Mount Sinai